PlainPill

Noopept

People mainly take Noopept for focus, memory, mood. Based on 365 first-hand reports and 0 meta-analyses & systematic reviews in the medical literature. Ranked #92 of 1,974 overall.

51
User score
Mixed
25% positive16% mixed12% negative47% unclear

Of reports that state an outcome, 47% are positive.

Clinical research
DNo human trials found
0
meta-analyses
0
RCTs
83
papers

What Noopept does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

DNo human trials found

No randomized controlled trials in humans found on PubMed. The grade measures how much human research exists — read the conclusions below for what it found.

No meta-analyses or systematic reviews published yet — 0 randomized trials found.

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

as neededas reported
15 mg2x daily
30 mgtwice daily
20 mgas reported
15 mgas reported
100 mgsingle dose

Reported side effects

How often each side effect came up across all reports.

brain fog ×13headache ×6anxiety ×6short term ×5irritability ×5depression ×4overstimulation ×1jitteriness ×1

What users say

Verbatim quotes, shortened only — each links to the original discussion.

“I have phenylpiracetam, aniracetam, oxiracetam, noopept (not techincally a racetam), and good ol' piracetam.”
Source discussion ↗
“the noopept in the old formula buzzed me out, was crazy”
Source discussion ↗
“Used Noopept, Oxiracetam and Phenyl, but don't really take anymore.”
Source discussion ↗
“Stocking Coluracetam, Phenylpiracetam, Noopept”
Source discussion ↗
“The 'vocabulary blanks' you speak of seem to be a side effect of Noopept.”
Source discussion ↗
Top discussions (5)

Other options for focus

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 2, 2026. How we rate